Geneva-based startup ABCDx develops diagnostic solutions for brain injuries. Its portable AI-based device, LVOCheck, is designed to identify biomarkers associated with Large Vessel Occlusion strokes within 15 minutes. ABCDx and its partners in the Eureka Consortium are conducting their first clinical study on 500 patients to optimize the sensitivity and specificity of biomarkers-based stroke diagnosis in pre-hospital settings.
